1.Tran-Dinh A, Levoye A, Lambert G, Louedec L, Journe C, Meilhac O, Amarenco P: Low levels of low-density lipoprotein-C associated with proprotein convertase subtilisin kexin 9 inhibition do not increase the risk of hemorrhagic transformation. Stroke 2014, 45(10):3086–3088.
2.Yaghi S, Willey JZ, Cucchiara B, Goldstein JN, Gonzales NR, Khatri P, Kim LJ, Mayer SA, Sheth KN, Schwamm LH: Treatment and Outcome of Hemorrhagic Transformation After Intravenous Alteplase in Acute Ischemic Stroke: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2017, 48(12):e343-e361.
3.Wu S, Wu B, Liu M, Chen Z, Wang W, Anderson CS, Sandercock P, Wang Y, Huang Y, Cui L et al: Stroke in China: advances and challenges in epidemiology, prevention, and management. The Lancet Neurology 2019, 18(4):394–405.
4.Bang OY, Saver JL, Liebeskind DS, Starkman S, Villablanca P, Salamon N, Buck B, Ali L, Restrepo L, Vinuela F et al: Cholesterol level and symptomatic hemorrhagic transformation after ischemic stroke thrombolysis. Neurology 2007, 68(10):737–742.
5.Kim BJ, Lee SH, Ryu WS, Kang BS, Kim CK, Yoon BW: Low level of low-density lipoprotein cholesterol increases hemorrhagic transformation in large artery atherothrombosis but not in cardioembolism. Stroke 2009, 40(5):1627–1632.
6.D’Amelio M, Terruso V, Famoso G, Ragonese P, Aridon P, Savettieri G: Cholesterol levels and risk of hemorrhagic transformation after acute ischemic stroke. Cerebrovascular diseases (Basel, Switzerland) 2011, 32(3):234–238.
7.Yang N, Lin M, Wang BG, Zeng WY, He YF, Peng HY, Zeng J, Wu ZY, Zhong Y: Low level of low-density lipoprotein cholesterol is related with increased hemorrhagic transformation after acute ischemic cerebral infarction. European review for medical and pharmacological sciences 2016, 20(4):673–678.
8.Puri R, Nissen SE, Shao M, Elshazly MB, Kataoka Y, Kapadia SR, Tuzcu EM, Nicholls SJ: Non-HDL Cholesterol and Triglycerides: Implications for Coronary Atheroma Progression and Clinical Events. Arteriosclerosis, thrombosis, and vascular biology 2016, 36(11):2220–2228.
9.Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P: Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis 2009, 202(1):289–295.
10.Verbeek R, Hovingh GK, Boekholdt SM: Non-high-density lipoprotein cholesterol: current status as cardiovascular marker. Current opinion in lipidology 2015, 26(6):502–510.
11.Sniderman A, McQueen M, Contois J, Williams K, Furberg CD: Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol? Journal of clinical lipidology 2010, 4(3):152–155.
12.Wu B, Lin S, Hao Z, Yang J, Xu Y, Wu L, Zhang S, Liu M: Proportion, risk factors and outcome of lacunar infarction: a hospital-based study in a Chinese population. Cerebrovascular diseases (Basel, Switzerland) 2010, 29(2):181–187.
13.Kong FY, Tao WD, Hao ZL, Liu M: Predictors of one-year disability and death in Chinese hospitalized women after ischemic stroke. Cerebrovascular diseases (Basel, Switzerland) 2010, 29(3):255–262.
14.Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T: Cerebrovascular disease in the community: results of a WHO collaborative study. Bulletin of the World Health Organization 1980, 58(1):113–130.
15.Brott T, Adams HP, Jr., Olinger CP, Marler JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20(7):864–870.
16.Jacobson TA, Ito MK, Maki KC, Orringer CE, Bays HE, Jones PH, McKenney JM, Grundy SM, Gill EA, Wild RA et al: National lipid association recommendations for patient-centered management of dyslipidemia: part 1—full report. Journal of clinical lipidology 2015, 9(2):129–169.
17.Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G et al: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998, 352(9136):1245–1251.
18.Pencina MJ, D’Agostino RB, Sr., D’Agostino RB, Jr., Vasan RS: Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statistics in medicine 2008, 27(2):157–172; discussion 207–112.
19.Elshazly MB, Martin SS, Blaha MJ, Joshi PH, Toth PP, McEvoy JW, Al-Hijji MA, Kulkarni KR, Kwiterovich PO, Blumenthal RS et al: Non-high-density lipoprotein cholesterol, guideline targets, and population percentiles for secondary prevention in 1.3 million adults: the VLDL–2 study (very large database of lipids). Journal of the American College of Cardiology 2013, 62(21):1960–1965.
20.Holewijn S, den Heijer M, Swinkels DW, Stalenhoef AF, de Graaf J: Apolipoprotein B, non-HDL cholesterol and LDL cholesterol for identifying individuals at increased cardiovascular risk. Journal of internal medicine 2010, 268(6):567–577.
21.Lin SF, Chao AC, Hu HH, Lin RT, Chen CH, Chan L, Lin HJ, Sun Y, Lin YY, Chen PL et al: Low Cholesterol Levels Increase Symptomatic Intracranial Hemorrhage Rates After Intravenous Thrombolysis: A Multicenter Cohort Validation Study. J Atheroscler Thromb 2018.
22.Hong CT, Chiu WT, Chi NF, Lai LY, Hu CJ, Hu HH, Chan L: Low-density lipoprotein level on admission is not associated with postintravenous thrombolysis intracranial hemorrhage in patients with acute ischemic stroke. J Investig Med 2018, 67(3):659–662.
23.Lin TC, Lin YK, Chen CI, Chan L, Chi NF, Yuan RY, Sheu JJ, Wei CR, Tsai JP, Yeh TH: Serum lipid level is not associated with symptomatic intracerebral hemorrhage after intravenous thrombolysis for acute ischemic stroke. PeerJ 2018, 6:e6021.
24.Messe SR, Pervez MA, Smith EE, Siddique KA, Hellkamp AS, Saver JL, Bhatt DL, Fonarow GC, Peterson ED, Schwamm LH: Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke. Stroke 2013, 44(5):1354–1359.
25.Wieberdink RG, Poels MM, Vernooij MW, Koudstaal PJ, Hofman A, van der Lugt A, Breteler MM, Ikram MA: Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arteriosclerosis, thrombosis, and vascular biology 2011, 31(12):2982–2989.
26.Thrift A, McNeil J, Donnan G: Reduced frequency of high cholesterol levels among patients with intracerebral haemorrhage. Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia 2002, 9(4):376–380.
27.Fessler MB, Rose K, Zhang Y, Jaramillo R, Zeldin DC: Relationship between serum cholesterol and indices of erythrocytes and platelets in the US population. Journal of lipid research 2013, 54(11):3177–3188.
28.Rosenson RS, McCormick A, Uretz EF: Distribution of blood viscosity values and biochemical correlates in healthy adults. Clinical chemistry 1996, 42(8 Pt 1):1189–1195.
29.Rosenson RS, Shott S, Tangney CC: Hypertriglyceridemia is associated with an elevated blood viscosity Rosenson: triglycerides and blood viscosity. Atherosclerosis 2002, 161(2):433–439.
30.Mahajan N, Ference BA, Arora N, Madhavan R, Bhattacharya P, Sudhakar R, Sagar A, Wang Y, Sacks F, Afonso L: Role of non-high-density lipoprotein cholesterol in predicting cerebrovascular events in patients following myocardial infarction. The American journal of cardiology 2012, 109(12):1694–1699.
31.Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DE et al: 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology 2018.
32.National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A: Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143–3421.
33.Zhu J, Gao R, Zhao S, Lu G, Zhao D, Li J: Guidelines for the prevention and treatment of dyslipidemia in Chinese adults (revised edition 2016). Chin Circul J 2016, 31(10):937–953.
34.Zhang Z, Pereira S, Luo M, Matheson E: Evaluation of Blood Biomarkers Associated with Risk of Malnutrition in Older Adults: A Systematic Review and Meta-Analysis. Nutrients 2017, 9(8).
35.Amirkalali B, Sharifi F, Fakhrzadeh H, Mirarefein M, Ghaderpanahi M, Badamchizadeh Z, Larijani B: Low serum leptin serves as a biomarker of malnutrition in elderly patients. Nutrition Research 2010, 30(5):314–319.